4.4 Article

Scallaradial, a dialdehyde-containing marine metabolite that causes an unexpected noncovalent PLA2 inactivation

Journal

CHEMBIOCHEM
Volume 8, Issue 13, Pages 1585-1591

Publisher

WILEY-V C H VERLAG GMBH
DOI: 10.1002/cbic.200700217

Keywords

anti-inflammatory agents; mass spectrometry; molecular modeling; natural products; phospholipase inactivation

Ask authors/readers for more resources

Several marine terpenoids that contain at least one reactive aldehyde group, such as manoalide and its congeners, possess interesting anti-inflammatory activities that are mediated by the covalent inactivation of secretary phospholipase A(2) (sPLA(2)). Scalaradial, a 1,4-dialdehyde marine terpenoid that was isolated from the sponge Cacospongia mollior, is endowed with a relevant anti-inflammatory profile, both in vitro and in vivo, through selective sPLA(2) inhibition. Due to its peculiar dialdehyde structural feature, it has been proposed that scalaradial exerts its enzymatic inactivation by means of an irreversible covalent modification of its target. In the context of our on-going research on anti-PLA(2) natural products and their interaction at a molecular level, we studied scalaradial in an attempt to shed more light on the molecular mechanism of its PLA(2) inhibition. A detailed analysis of the reaction profile between scalarodial and bee venom PLA(2), a model sPLA(2) that shares a high structural homology with the human synovial enzyme, was performed by a combination of spectroscopic techniques, chemical reactions (selective modifications, biomimetic reactions), and classical protein chemistry (such as proteolytic digestion, HPLC and mass spectrometry), along with molecular modeling, studies. Unexpectedly, our data clearly indicated the noncovalent forces to be the leading event in the PLA(2) inactivation process; thus, the, covalent modification of the enzyme emerges as only a minor side event in the ligand enzyme interaction. The overall picture might be useful in the design of SLD analogues as new potential anti-inflammatory compounds that, target sPLA(2) enzymes.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available